Duramed Pharmaceuticals Articles

Watson challenges Exelon patent; wins Seasonique appeal; launches generic Kadian

13 November 2011

Watson debuts generic Seasonique in USA

28 July 2011

Barr's LoSeasonique approved in the USA

3 November 2008

Senior management changes at Barr

7 April 2008

Barr unit sues Watson and Sandoz over Seasonale patent

24 December 2007

Canada clears Seasonale OC

16 July 2007

Duramed's Enjuvia gets two FDA appros

7 May 2007

Pharma/biotech mergers and acquisitions during 2005

6 February 2006

Round-up of pharmaceutical mergers and acquisitions during 2001

9 January 2006

Barr and Galen announce Loestrin and Ovcon 35 deals

5 April 2004

Barr second-quarter earnings leap on sales of generic Prozac

4 February 2002

Barr Labs raises 2002 earnings estimates

7 December 2001

Huge leap in net income at Duramed Pharmaceuticals

24 October 2001

PwC report looks at M&A activity in first half of 2001 for pharma and

4 October 2001

Duramed completes $10 million placement

16 May 2000

Duramed launches Cenestin

29 July 1999

Duramed looks to Cenestin for growth

6 April 1999

Duramed To File NDA For Cenestin

2 April 1998

Duramed To File For Conjugated Estrogens

26 February 1998

Duramed Deal With W-L

29 September 1997

Duramed Takes On FDA Over Generic Premarin Block

31 July 1997

Duramed Move In Premarin Fracas

16 October 1995

Solid 3rd Qtr Growth For Large Pharma Cos

31 October 1994

Showing 1-23 of 23 articles

Go to beginningPrevious
  • 1
NextGo to end